Merrimack Pharmaceuticals Inc. (Nasdaq: MACK) will offer $50 million worth of common stock and $75 million worth of convertible senior notes. The stock price plummeted $1.96 to close at $5.03.
Merrimack To Offer Stock
July 11, 2013 at 16:58 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||